FOXO4-DRI (Proxofim) FOXO4-DRI (Proxofim) is a synthetic peptide studied for its ability to target senescent cells by disrupting FOXO4p53 interactions
Improves skins appearance Helps promote relaxation and reduces stress A general state of health is your greatest defense No drugs, or stimulants Patented proprietary form of phototherapy What is Phototherapy
Published research (Stoeva MK et al., Gut Microbes, 2021) on Clostridium butyricum confirms it is a direct butyrate-producing organism in the gut
Peptide therapies like AOD9604 or tesamorelin can play a complementary role in bodycomposition and metabolic wellness, but outside of tesamorelins HIV indication, their weightloss evidence base is smaller and they should be framed as adjunctive tools rather than replacements for wellstudied GLP1 treatments
DSIP is studied within integrated models exploring how modulation of one domain influences the others
As an analogue of amylin, it is designed to be more stable and long-acting, overcoming some of the limitations of the natural peptide ( 6, 7 )
